Heart Failure, Preserved Ejection Fraction: Clinical Trials

1 trial for Heart Failure, Preserved Ejection Fraction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Heart Failure, Preserved Ejection Fraction: new trials by email Literature Review of Heart Failure, Preserved Ejection Fraction trials Research Report on Heart Failure, Preserved Ejection Fraction

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction
SGLT2 inhibitor - Heart Failure, Preserved Ejection Fraction
Phase 4UnknownSamsung Medical Center1542024-05-012024-04-08

Narrower conditions

Heart Failure, Diastolic (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Heart Failure (1)

Interventions

Sodium-Glucose Transporter 2 Inhibitors (1)

Sponsors

Samsung Medical Center (1)

Countries

South Korea (1)

Top investigators

Jeong Hoon Yang, MD, PhD (1)